ServiceNow, Live Nation Entertainment And A Health Care Stock: CNBC's 'Final Trades'

Benzinga
Aug 22

On CNBC's “Halftime Report Final Trades,” Malcolm Ethridge, managing partner at Capital Area Planning Group, said ServiceNow, Inc. NOW is around 25% off its 52-week high. It has become a victim of its own success, so it’s probably creating an attractive entry point, he added.

On the earnings front, ServiceNow reported second-quarter revenue of approximately $3.22 billion on July 23, beating the consensus estimate of $3.12 billion, according to Benzinga Pro. The company reported second-quarter adjusted earnings of $4.09 per share, beating analyst estimates of $3.57 per share.

Jenny Van Leeuwen Harrington, chief executive officer of Gilman Hill Asset Management, LLC, said Bristol-Myers Squibb Company BMY has a 5.5% dividend yield and has paid dividends for 55 straight years. It is not an aristocrat because it hasn’t increased in all those years, but it’s still a great stock, she added.

Lending support to her choice, Bristol-Myers Squibb, on July 31, reported better-than-expected second-quarter sales and raised its FY25 sales guidance above estimates.

Don't forget to check out our premarket coverage here

Joshua Brown, co-founder and CEO of Ritholtz Wealth Management, named Live Nation Entertainment, Inc. LYV as his final trade.

Supporting his view, MoffettNathanson analyst Robert Fishman, on Aug. 18, initiated coverage on Live Nation Entertainment with a Buy rating and announced a price target of $195.

Price Action:

Check This Out:

Photo via Shutterstock

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10